Pharmacogenetics & Pharmacogenomics

Pharmacogenetics and pharmacogenomics (pgx) are rapidly growing fields that aim to elucidate the genetic basis for the interindividual differences in drug response. Here is the latest research on pharmacogenetics and pharmacogenomics.

June 26, 2020

The effects of CYP2C9 and VKORC1 gene polymorphisms on warfarin maintenance dose in Turkish cardiac patients

Future Cardiology
Cansu Selcan AkdenizBelgin Susleyici
June 25, 2020
Open Access

The genetic and pharmacogenomic landscape of snoRNAs in human cancer

Molecular Cancer
Yaoming LiuLeng Han
June 26, 2020
Open Access

Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population

Scientific Reports
Darlen Cardoso de CarvalhoNey Pereira Carneiro Dos Santos
June 25, 2020

Obesity alters endoxifen plasma levels in young breast cancer patients: A pharmacometric simulation approach

Clinical Pharmacology and Therapeutics
Anna Mueller-SchoellCharlotte Kloft
July 2, 2020

Interventions to improve medication adherence in mental health: the update of a systematic review of cost-effectiveness

International Journal of Psychiatry in Clinical Practice
Lidia García-PérezTasmania Del Pino-Sedeño
June 23, 2020
Review
Open Access

Machine learning approaches to drug response prediction: challenges and recent progress

NPJ Precision Oncology
George AdamAnna Goldenberg
June 25, 2020
Review
Open Access

The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

Journal of Clinical Medicine
Ramon Andrade De MelloGeorgios Antoniou
July 1, 2020
Open Access

Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β

Terapevticheskiĭ arkhiv
N V BakulinaD N Andreev
July 1, 2020

Pharmacogenetics in the treatment of gastrointestinal stromal tumors- an updated review

Expert Opinion on Drug Metabolism & Toxicology
Gloria RavegniniSabrina Angelini
June 24, 2020

Integrating Pharmacogenetic Decision Support into a Clinical Information System

Studies in Health Technology and Informatics
Kevin TippenhauerThomas Bürkle
July 2, 2020

Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients

Drug Metabolism and Personalized Therapy
Lettilia XhakazaMongi Benjeddou
June 27, 2020

Public interest in whole genome sequencing and information needs: an online survey study

Personalized Medicine
Holly EtchegaryDaryl Pullman
June 26, 2020
Comment / Editorial
Open Access

Pharmacogenomics and Personalized Medicine

Genes
Erika Cecchin, Gabriele Stocco

Sign up to follow this feed and discover related papers.

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2020 Meta ULC. All rights reserved
/feed-previews/pharmacogenetics-pharmacogenomics/ce120dba-6481-4e9e-bd33-27c6efc6d1b3